Sanjeev Misra
Impact in
- Otorhinolaryngology top 2%
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 epidemiological studies 19
- Co-authors
- Arun ChaturvediPraveen SharmaKuldeep SinghKiran SharmaPrasenjit MitraVijay KumarPankaj BhardwajBalraj Mittal
- Journals
- Tumor Biology (6 papers)Journal of Surgical Oncology (4 papers)Urologic Oncology Seminars and Original Investigations (3 papers)Infection and Drug Resistance (3 papers)Scientific Reports (2 papers)
- Partner nations
- IndiaSouth KoreaUnited States
In The Last Decade
Sanjeev Misra
176 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Otorhinolaryngology 186
- Infectious Diseases 672
- Oncology 925
- Surgery 1.2k
- Cancer Research 409
Countries citing papers authored by Sanjeev Misra
This map shows the geographic impact of Sanjeev Misra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjeev Misra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjeev Misra more than expected).
Fields of papers citing papers by Sanjeev Misra
This network shows the impact of papers produced by Sanjeev Misra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjeev Misra. The network helps show where Sanjeev Misra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sanjeev Misra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 22 | |
| 9 | 2021 | 24 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 180 | |
| 13 | 2020 | 53 | |
| 14 | Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database | 2020 | 6 |
| 15 | 2020 | 86 | |
| 16 | 2019 | 31 | |
| 17 | 2016 | 22 | |
| 18 | A study on local expression of NF-κB, CCL2 and their involvement in intratumoral macrophage infiltration in breast cancer. | 2016 | 4 |
| 19 | 2014 | 24 | |
| 20 | 2000 | 40 |
About Sanjeev Misra
Sanjeev Misra is a scholar working on Modeling and Simulation, Otorhinolaryngology, Infectious Diseases, Oncology and Cancer Research, having authored 190 papers that have together received 3.7k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (36 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (34 papers), SARS-CoV-2 and COVID-19 Research (22 papers), COVID-19 epidemiological studies (19 papers), COVID-19 and healthcare impacts (17 papers), Long-Term Effects of COVID-19 (11 papers), COVID-19 Pandemic Impacts (10 papers) and MicroRNA in disease regulation (10 papers). The work is most often cited by research in Otorhinolaryngology (186 citations), Infectious Diseases (672 citations), Oncology (925 citations), Surgery (1.2k citations) and Cancer Research (409 citations). Sanjeev Misra has collaborated with scholars based in India, South Korea and United States. Frequent co-authors include Arun Chaturvedi, Praveen Sharma, Kuldeep Singh, Kiran Sharma, Prasenjit Mitra, Vijay Kumar, Pankaj Bhardwaj, Balraj Mittal, Ashok Kumar and Jaykaran Charan. Their work appears in journals such as Tumor Biology, Journal of Surgical Oncology, Urologic Oncology Seminars and Original Investigations, Infection and Drug Resistance and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.